|1.||Bulut, Gamze B: 1 article (03/2010)|
|2.||Shen, Yu-Min: 1 article (03/2010)|
|3.||Huang, Lily J: 1 article (03/2010)|
|4.||Prchal, Josef T: 1 article (10/2005)|
|5.||Skoda, Radek: 1 article (10/2005)|
|6.||Arcasoy, Murat O: 1 article (04/2005)|
|7.||Karayal, Aysen F: 1 article (04/2005)|
|8.||Cario, H: 1 article (03/2005)|
|9.||Prchal, J T: 1 article (02/2000)|
|10.||Kralovics, R: 1 article (02/2000)|
02/01/2000 - "The best characterized primary polycythemia is the autosomal dominant primary familial and congenital polycythemia (PFCP). "
01/01/1999 - "A careful clinical history may reveal whether this idiopathic erythrocytosis is likely to be congenital and/or familial, in which case the term "primary familial and congenital polycythemia" is sometimes applied. "
11/01/1997 - "Primary familial and congenital polycythemia (PFCP or familial erythrocytosis) is a rare hematological disorder with either autosomal-dominant inheritance or sporadic occurrence. "
10/01/2005 - "Patients with the congenital polycythemic condition "primary familial and congenital polycythemia" (PFCP) have characteristically decreased erythropoietin (Epo) levels similar to PV, hypersensitive erythroid progenitors, and low Epo levels; as such, this condition is often confused with PV. Therefore, PFCP will also be discussed here, while other congenital polycythemic states such as the Chuvash polycythemia that have elevated or inappropriately normal Epo levels will be omitted from this review in view of their distinct phenotype and unique laboratory features."
04/15/2005 - "Erythropoietin receptor (EPOR) gene mutations leading to truncations of the cytoplasmic, carboxy-terminal region of EPOR have been described in some patients with primary familial and congenital polycythemia (PFCP), a disorder characterized by isolated erythrocytosis and increased sensitivity of erythroid progenitors to Epo. "
03/01/2010 - "Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). "
04/15/2005 - "Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain."
07/01/1998 - "Primary familial and congenital polycythemia (PFCP or familial erythrocytosis) is a rare proliferative disorder of erythroid progenitor cells, characterized by elevated erythrocyte mass and hemoglobin concentration, hypersensitivity of erythroid progenitors to erythropoietin (EPO), and autosomal dominant inheritance or sporadic occurrence. "
|4.||Myeloproliferative Disorders (Myeloproliferative Disorder)
|3.||Erythropoietin Receptors (Erythropoietin Receptor)